专利检索 ap:("MUSC FOUNDATION FOR RESEARCH DEVELOPMENT") AND inv:"ROBINSON, Reeder M." 第 1 页

1.

发明申请
AN AGR2Xcd3 BISPECIFIC ENGAGER FOR THE TREATMENT OF CANCER 审中-公开

公开(公告)号：WO2022150803A1

公开(公告)日：2022-07-14

申请号：PCT/US2022/070009

申请日：2022-01-04

申请人： MUSC FOUNDATION FOR RESEARCH DEVELOPMENT

发明人： DOLLOFF, Nathan G. , ROBINSON, Reeder M.

IPC分类号： A61K39/395 , C07K16/28 , G01N33/574

摘要： The present disclosure is directed to antibodies binding to AGR2 and cancer cells that express or overexpress AGR2, and methods for use thereof.

2.

发明申请
INDENE DERIVATIVES AND USES THEREOF 审中-公开

公开(公告)号：WO2019046368A1

公开(公告)日：2019-03-07

申请号：PCT/US2018/048449

申请日：2018-08-29

申请人： MUSC FOUNDATION FOR RESEARCH DEVELOPMENT

发明人： DOLLOFF, Nathan G. , ROBINSON, Reeder M. , REITZ, Allen B. , BIAN, Haiyan

IPC分类号： C07C233/23 , C07C233/41 , C07C235/36

摘要： The present invention relates to compounds of formula (I) :, including any stereochemically isomeric form thereof, or pharmaceutically acceptable salts thereof, for the treatment of, for example, cancer.